Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques‐Eric Gottenberg, Xavier Mariette, Zahir Amoura et al.|RMD Open|2022Cited by 4
Tolérance et efficacité des thérapies ciblées prescrites hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Autoimmune Diseases)Jacques‐Eric Gottenberg, Xavier Mariette, A. Chaudier et al.|Revue du Rhumatisme|2021Cited by 0